Skip to Main Content

Paper Details

Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Nat Med
20
2018
atezolizumab, bevacizumab, renal cell carcinoma, sunitinib
Author NameAffiliation
Lawrence FongUniversity of California, San Francisco School of Medicine
Richard W JosephMayo Clinic Hospital -Florida
Wendy Kimryn RathmellVanderbilt University Medical Center
Toni K ChoueiriDana-Farber Cancer Institute
Suchit JhunjhunwalaInc.
  • 1 - 5

Datasets

Release 1.2